| Item | Value |
|---|---|
| DrugBank ID | DB00190 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 24 |
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | parkinsonian-pyramidal syndrome | TxGNN Knowledge Graph |
| 2 | parkinsonian disorder | TxGNN Knowledge Graph |
| 3 | X-linked parkinsonism-spasticity syndrome | TxGNN Knowledge Graph |
| 4 | early-onset parkinsonism-intellectual disability syndrome | TxGNN Knowledge Graph |
| 5 | hemiparkinsonism-hemiatrophy syndrome | TxGNN Knowledge Graph |
| 6 | atypical juvenile parkinsonism | TxGNN Knowledge Graph |
| 7 | parkinsonian-pyramidal syndrome | TxGNN Knowledge Graph |
| 8 | parkinsonian disorder | TxGNN Knowledge Graph |
| 9 | X-linked parkinsonism-spasticity syndrome | TxGNN Knowledge Graph |
| 10 | early-onset parkinsonism-intellectual disability syndrome | TxGNN Knowledge Graph |
| 11 | hemiparkinsonism-hemiatrophy syndrome | TxGNN Knowledge Graph |
| 12 | atypical juvenile parkinsonism | TxGNN Knowledge Graph |
| 13 | parkinsonian-pyramidal syndrome | TxGNN Knowledge Graph |
| 14 | parkinsonian disorder | TxGNN Knowledge Graph |
| 15 | X-linked parkinsonism-spasticity syndrome | TxGNN Knowledge Graph |
| 16 | early-onset parkinsonism-intellectual disability syndrome | TxGNN Knowledge Graph |
| 17 | hemiparkinsonism-hemiatrophy syndrome | TxGNN Knowledge Graph |
| 18 | atypical juvenile parkinsonism | TxGNN Knowledge Graph |
| 19 | parkinsonian-pyramidal syndrome | TxGNN Knowledge Graph |
| 20 | parkinsonian disorder | TxGNN Knowledge Graph |
| 21 | X-linked parkinsonism-spasticity syndrome | TxGNN Knowledge Graph |
| 22 | early-onset parkinsonism-intellectual disability syndrome | TxGNN Knowledge Graph |
| 23 | hemiparkinsonism-hemiatrophy syndrome | TxGNN Knowledge Graph |
| 24 | atypical juvenile parkinsonism | TxGNN Knowledge Graph |
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.